Oblique parallel incisions in 25G surgery improves healing

Article

Performing 25-gauge pars plana vitrectomy with oblique parallel incisions rather than with standard straight incisions, may allow for more complete postoperative wound sealing.

Performing 25-gauge pars plana vitrectomy with oblique parallel incisions rather than with standard straight incisions, may allow for more complete postoperative wound sealing, according to a report published in the September issue of Graefe's Archive for Clinical and Experimental Ophthalmology.

Stanislao Rizzo and colleagues from the Santa Chiara Hospital, Pisa, Italy enrolled 45 patients with macular holes. In 15 eyes, operations were carried out using oblique parallel insertion, in a further 15, oblique perpendicular insertions were used, and the remaining 15 received straight incisions (SI). Each patient underwent ultrasound biomicroscopy (UBM) examinations, one day, one week and one month postoperatively.

Oblique parallel insertions healed immediately following removal of the 25-gauge cannula. At one day postoperatively, all sclerotomies were well-healed with the internal wound lips showing excellent apposition. In addition, 39 sclerotomies were undetectable by UBM and six were only just observable.

In the oblique perpendicular insertion group, the incisions also healed immediately and all sclerotomies were well-healed by one day postoperatively. However, minimal gape was visible on UBM. Three eyes also showed peripheral cilio-choroidal detachment at one day postoperatively — this was resolved in all cases by seven days follow-up.

In the straight incision group, 10 cases of conjunctival blebs developed. Of these, seven required air-gas refilling and three required suturing of the sclerotomies. By one day postoperatively, five subjects developed hypotony and UBM demonstrated significant gaps in all sites.

The authors concluded that oblique parallel incisions allow for better postoperative wound sealing.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Related Content
© 2025 MJH Life Sciences

All rights reserved.